Afrezza (insulin human) prior authorization
Defines UnitedHealthcare Pharmacy prior authorization and medical necessity criteria for Afrezza (insulin human) for adult patients with diabetes who are unable to self-inject short‑acting insulin. Affects clinicians prescribing Afrezza and pharmacy authorization processes.
No material clinical or coverage changes in this revision.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.